You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

STI571 (Gleevec)

Showing 26 - 50 of 265
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Canada, United States (Dasatinib, Imatinib Mesylate, Laboratory

Active, not recruiting
Has Results
  • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Burbank, California
  • +340 more
Jan 28, 2023

Myelogenous Leukemia, Chronic, Chronic Phase Trial in Houston (Gleevec)

Terminated
Has Results
  • Myelogenous Leukemia, Chronic, Chronic Phase
  • Houston, Texas
    MD Anderson Cancer Center
Sep 11, 2018

Melanoma, Skin Tumors Trial in Houston (Imatinib mesylate (STI571))

Completed
  • Melanoma
  • Skin Neoplasms
  • Imatinib mesylate (STI571)
  • Houston, Texas
    University of Texas - MD Anderson Cancer Center
Oct 30, 2018

Chronic Myeloid Leukemia Trial in Poitiers (Imatinib mesylate 400 mg, Imatinib mesylate 600 mg, Imatinib 400 mg +

Completed
  • Chronic Myeloid Leukemia
  • Imatinib mesylate 400 mg
  • +3 more
  • Poitiers, France
    University Hospital
Apr 10, 2020

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Uijeongbu si (Asciminib single agent, Asciminib, Imatinib)

Recruiting
  • Chronic Myelogenous Leukemia
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Asciminib single agent
  • +5 more
  • Ann Arbor, Michigan
  • +49 more
Jan 26, 2023

CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic Trial in Worldwide (Asciminib add-on, Imatinib, Nilotinib)

Recruiting
  • CML
  • +3 more
  • Asciminib add-on
  • +3 more
  • Augusta, Georgia
  • +46 more
Jan 23, 2023

3rd Line GIST Trial in Worldwide (STI571, BKM120)

Completed
  • 3rd Line GIST
  • Boston, Massachusetts
  • +10 more
Dec 17, 2020

Melanoma Trial in Seoul (regorafenib)

Recruiting
  • Melanoma
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
Apr 1, 2021

Recurrent Gastric Cancer, Stage IV Gastric Cancer Trial in Duarte (imatinib mesylate, laboratory biomarker analysis)

Completed
Has Results
  • Recurrent Gastric Cancer
  • Stage IV Gastric Cancer
  • imatinib mesylate
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope
Jun 15, 2018

Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia, Leukemia Trial in Atlanta (Dasatinib, Imatinib Mesylate, Nilotinib)

Terminated
Has Results
  • Chronic Myelogenous Leukemia
  • +2 more
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Nov 1, 2018

Chronic Myeloid Leukemia Trial in Worldwide (nilotinib)

Active, not recruiting
Has Results
  • Chronic Myeloid Leukemia
  • Los Angeles, California
  • +61 more
Mar 17, 2022

Breast Cancer Trial in Baltimore (docetaxel, imatinib mesylate)

Completed
  • Breast Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Apr 22, 2018

Stage IIIA Skin Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma Trial (drug, other, biological)

Withdrawn
  • Stage IIIA Skin Melanoma
  • +3 more
  • Imatinib Mesylate
  • +2 more
  • (no location specified)
Apr 3, 2018

B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Recurrent Adult Acute Lymphoblastic Leukemia Trial in Seattle (drug,

Withdrawn
  • B Acute Lymphoblastic Leukemia
  • +8 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 9, 2018

Eosinophilia, Hypereosinophilic Syndrome Trial in Stanford (Gleevec)

Terminated
  • Eosinophilia
  • Hypereosinophilic Syndrome
  • Stanford, California
    Stanford University School of Medicine
May 5, 2021

Gastrointestinal Stromal Tumors Trial (Perifosine, Imatinib Mesylate)

Completed
  • Gastrointestinal Stromal Tumors
  • (no location specified)
Feb 20, 2018

Adult Anaplastic Oligodendroglioma, Adult Mixed Glioma, Adult Oligodendroglioma Trial in United States (Imatinib Mesylate,

Completed
Has Results
  • Adult Anaplastic Oligodendroglioma
  • +3 more
  • Imatinib Mesylate
  • +2 more
  • Scottsdale, Arizona
  • +228 more
Oct 4, 2019

Mesothelioma, Malignant Trial in Rozzano (Gemcitabine, Imatinib mesylate)

Completed
  • Mesothelioma, Malignant
  • Rozzano, MI, Italy
    Istituto Clinico Humanitas
Jan 20, 2021

Myeloid Leukemia, Chronic, Chronic Phase Trial in Newcastle-upon-Tyne (Imatinib, Dasatinib)

Completed
  • Myeloid Leukemia, Chronic, Chronic Phase
  • Newcastle-upon-Tyne, United Kingdom
    Freeman Hospital
Apr 20, 2018

Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive Trial in Worldwide (Imatinib, Nilotinib, Bosutinib)

Recruiting
  • Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
  • Longmont, Colorado
  • +128 more
Aug 1, 2022

Prostate Cancer Trial in Houston (imatinib mesylate, docetaxel)

Completed
  • Prostate Cancer
  • Houston, Texas
    U.T. M.D. Anderson Cancer Center
Oct 30, 2018

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in United States (Bosutinib, Dasatinib, Laboratory Biomarker

Active, not recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Anchorage, Alaska
  • +540 more
Dec 14, 2022

Gastrointestinal Stromal Tumors, Resected Gastrointestinal Stromal Tumors, Non-metastatic Trial in France (Imatinib maintenance)

Recruiting
  • Gastrointestinal Stromal Tumors
  • +4 more
  • Imatinib maintenance
  • Marseille, Bouches Du Rhône, France
  • +16 more
Jul 28, 2021

Sarcoma Trial in Helsinki (Imatinib)

Recruiting
  • Sarcoma
  • Helsinki, Finland
    Helsinki University Central Hospital
Sep 26, 2022

3rd Line GIST Trial in Worldwide (ST571 + BYL719)

Completed
  • 3rd Line GIST
  • ST571 + BYL719
  • Portland, Oregon
  • +10 more
Dec 17, 2020